这是一篇来自已证抗体库的有关人类 Nbs1的综述,是根据23篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合Nbs1 抗体。
Nbs1 同义词: AT-V1; AT-V2; ATV; NBS; NBS1; P95

GeneTex
小鼠 单克隆(1D7)
  • 免疫印迹; 人类; 1:1000; 图 3a
GeneTex Nbs1抗体(Genetex, GTX70224)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3a). Mol Oncol (2016) ncbi
小鼠 单克隆(1C3)
  • 免疫印迹; 人类; 图 s1c
GeneTex Nbs1抗体(Gene Tex, GTX70222)被用于被用于免疫印迹在人类样本上 (图 s1c). Cell Death Differ (2016) ncbi
小鼠 单克隆(1C3)
  • 免疫印迹; 人类; 图 5
GeneTex Nbs1抗体(GeneTex, GTX70222)被用于被用于免疫印迹在人类样本上 (图 5). BMC Biol (2015) ncbi
小鼠 单克隆(1D7)
  • 免疫沉淀; 人类; 图 6
GeneTex Nbs1抗体(Genetex, GTX70224)被用于被用于免疫沉淀在人类样本上 (图 6). Nat Cell Biol (2014) ncbi
小鼠 单克隆(1D7)
  • 免疫印迹; 人类
GeneTex Nbs1抗体(Genetex, GTX70224)被用于被用于免疫印迹在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(1D7)
  • 免疫印迹; 人类; 图 1
GeneTex Nbs1抗体(GeneTex, GTX70224)被用于被用于免疫印迹在人类样本上 (图 1). Oncogenesis (2012) ncbi
小鼠 单克隆(1C3)
  • 免疫印迹; 人类
GeneTex Nbs1抗体(GeneTex, #GTX70222)被用于被用于免疫印迹在人类样本上. Cancer Res (2011) ncbi
艾博抗(上海)贸易有限公司
domestic rabbit 单克隆(Y112)
  • 免疫印迹; 人类; 图 2a, 5b
艾博抗(上海)贸易有限公司 Nbs1抗体(Abcam, ab32074)被用于被用于免疫印迹在人类样本上 (图 2a, 5b). Genes Dev (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 2a
艾博抗(上海)贸易有限公司 Nbs1抗体(Abcam, ab47272)被用于被用于免疫印迹在人类样本上 (图 2a). Oncotarget (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 2
艾博抗(上海)贸易有限公司 Nbs1抗体(Abcam, ab23996)被用于被用于免疫印迹在人类样本上 (图 2). PLoS Genet (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 2
艾博抗(上海)贸易有限公司 Nbs1抗体(Abcam, ab47272)被用于被用于免疫印迹在人类样本上 (图 2). PLoS Genet (2016) ncbi
domestic rabbit 单克隆(Y112)
  • 免疫印迹; 人类; 图 1
艾博抗(上海)贸易有限公司 Nbs1抗体(Abcam, ab32074)被用于被用于免疫印迹在人类样本上 (图 1). BMC Cancer (2016) ncbi
圣克鲁斯生物技术
小鼠 单克隆
  • 免疫印迹; 人类; 1:1000; 图 s10a, s10b
圣克鲁斯生物技术 Nbs1抗体(Santa Cruz, sc-515069)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 s10a, s10b). Nat Commun (2021) ncbi
Novus Biologicals
小鼠 单克隆(1D7)
  • 免疫印迹; 小鼠; 图 2a
Novus Biologicals Nbs1抗体(Novus Biologicals, catalog NB100-221)被用于被用于免疫印迹在小鼠样本上 (图 2a). J Clin Invest (2015) ncbi
赛信通(上海)生物试剂有限公司
domestic rabbit 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Nbs1抗体(Cell Signalling Technologies, 3002S)被用于被用于免疫印迹在人类样本上. elife (2020) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 4c
赛信通(上海)生物试剂有限公司 Nbs1抗体(Cell Signaling, 3002)被用于被用于免疫印迹在人类样本上 (图 4c). Oncogene (2019) ncbi
domestic rabbit 多克隆
  • reverse phase protein lysate microarray; 小鼠; 图 s1.b,c
赛信通(上海)生物试剂有限公司 Nbs1抗体(Cell Signaling Technology, 3002)被用于被用于reverse phase protein lysate microarray在小鼠样本上 (图 s1.b,c). EMBO Mol Med (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:500; 图 4
赛信通(上海)生物试剂有限公司 Nbs1抗体(Cell Signaling Technology, 3001)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 4). Nat Genet (2016) ncbi
碧迪BD
小鼠 单克隆(13/P95PKL)
  • 免疫印迹; 人类; 图 1
碧迪BD Nbs1抗体(BD Transduction Laboratorie, 611388)被用于被用于免疫印迹在人类样本上 (图 1). PLoS Pathog (2015) ncbi
小鼠 单克隆(34/NBS1)
  • 免疫细胞化学; 小鼠; 1:10; 图 3g,h
碧迪BD Nbs1抗体(BD Biosciences, 611870)被用于被用于免疫细胞化学在小鼠样本上浓度为1:10 (图 3g,h). Development (2015) ncbi
小鼠 单克隆(34/NBS1)
  • 免疫印迹; 人类
碧迪BD Nbs1抗体(BD Biosciences, 611871)被用于被用于免疫印迹在人类样本上. Carcinogenesis (2014) ncbi
小鼠 单克隆(34/NBS1)
  • 免疫细胞化学; 小鼠
碧迪BD Nbs1抗体(BD Biosciences, 611871)被用于被用于免疫细胞化学在小鼠样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(34/NBS1)
  • 免疫印迹; 人类
碧迪BD Nbs1抗体(BD, 611870)被用于被用于免疫印迹在人类样本上. PLoS ONE (2012) ncbi
小鼠 单克隆(34/NBS1)
  • 免疫印迹; 小鼠
碧迪BD Nbs1抗体(BD Biosciences, 611871)被用于被用于免疫印迹在小鼠样本上. Int J Cancer (2013) ncbi
文章列表
  1. Nam J, Kim A, Choi S, Kim J, Choi K, Cho S, et al. An antibody against L1 cell adhesion molecule inhibits cardiotoxicity by regulating persistent DNA damage. Nat Commun. 2021;12:3279 pubmed 出版商
  2. Lochab S, Singh Y, Sengupta S, Nandicoori V. Mycobacterium tuberculosis exploits host ATM kinase for survival advantage through SecA2 secretome. elife. 2020;9: pubmed 出版商
  3. Urtishak K, Wang L, Culjkovic Kraljacic B, Davenport J, Porazzi P, Vincent T, et al. Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia. Oncogene. 2019;38:2241-2262 pubmed 出版商
  4. Gong Y, Handa N, Kowalczykowski S, de Lange T. PHF11 promotes DSB resection, ATR signaling, and HR. Genes Dev. 2017;31:46-58 pubmed 出版商
  5. Weber A, Drobnitzky N, Devery A, Bokobza S, Adams R, Maughan T, et al. Phenotypic consequences of somatic mutations in the ataxia-telangiectasia mutated gene in non-small cell lung cancer. Oncotarget. 2016;7:60807-60822 pubmed 出版商
  6. Gruosso T, Mieulet V, Cardon M, Bourachot B, Kieffer Y, Devun F, et al. Chronic oxidative stress promotes H2AX protein degradation and enhances chemosensitivity in breast cancer patients. EMBO Mol Med. 2016;8:527-49 pubmed 出版商
  7. Byrd P, Stewart G, Smith A, Eaton C, Taylor A, Guy C, et al. A Hypomorphic PALB2 Allele Gives Rise to an Unusual Form of FA-N Associated with Lymphoid Tumour Development. PLoS Genet. 2016;12:e1005945 pubmed 出版商
  8. Chang L, Huang J, Wang K, Li J, Yan R, Zhu L, et al. Targeting Rad50 sensitizes human nasopharyngeal carcinoma cells to radiotherapy. BMC Cancer. 2016;16:190 pubmed 出版商
  9. Rasmussen R, Gajjar M, Jensen K, Hamerlik P. Enhanced efficacy of combined HDAC and PARP targeting in glioblastoma. Mol Oncol. 2016;10:751-63 pubmed 出版商
  10. Harley M, Murina O, Leitch A, Higgs M, Bicknell L, Yigit G, et al. TRAIP promotes DNA damage response during genome replication and is mutated in primordial dwarfism. Nat Genet. 2016;48:36-43 pubmed 出版商
  11. Gramolelli S, Weidner Glunde M, Abere B, Viejo Borbolla A, Bala K, Rückert J, et al. Inhibiting the Recruitment of PLCγ1 to Kaposi's Sarcoma Herpesvirus K15 Protein Reduces the Invasiveness and Angiogenesis of Infected Endothelial Cells. PLoS Pathog. 2015;11:e1005105 pubmed 出版商
  12. Fedoriw A, Menon D, Kim Y, Mu W, Magnuson T. Key mediators of somatic ATR signaling localize to unpaired chromosomes in spermatocytes. Development. 2015;142:2972-80 pubmed 出版商
  13. Xie L, Pi X, Townley Tilson W, Li N, Wehrens X, Entman M, et al. PHD2/3-dependent hydroxylation tunes cardiac response to β-adrenergic stress via phospholamban. J Clin Invest. 2015;125:2759-71 pubmed 出版商
  14. Petroni M, Sardina F, Heil C, Sahún Roncero M, Colicchia V, Veschi V, et al. The MRN complex is transcriptionally regulated by MYCN during neural cell proliferation to control replication stress. Cell Death Differ. 2016;23:197-206 pubmed 出版商
  15. Harten S, Oey H, Bourke L, Bharti V, Isbel L, Daxinger L, et al. The recently identified modifier of murine metastable epialleles, Rearranged L-Myc Fusion, is involved in maintaining epigenetic marks at CpG island shores and enhancers. BMC Biol. 2015;13:21 pubmed 出版商
  16. Larsen D, Hari F, Clapperton J, Gwerder M, Gutsche K, Altmeyer M, et al. The NBS1-Treacle complex controls ribosomal RNA transcription in response to DNA damage. Nat Cell Biol. 2014;16:792-803 pubmed 出版商
  17. Shamanna R, Singh D, Lu H, Mirey G, Keijzers G, Salles B, et al. RECQ helicase RECQL4 participates in non-homologous end joining and interacts with the Ku complex. Carcinogenesis. 2014;35:2415-24 pubmed 出版商
  18. Lee J, Guo Z, Myler L, Zheng S, Paull T. Direct activation of ATM by resveratrol under oxidizing conditions. PLoS ONE. 2014;9:e97969 pubmed 出版商
  19. Clynes D, Jelinska C, Xella B, Ayyub H, Taylor S, Mitson M, et al. ATRX dysfunction induces replication defects in primary mouse cells. PLoS ONE. 2014;9:e92915 pubmed 出版商
  20. Sappino A, Buser R, Seguin Q, Fernet M, Lesne L, Gumy Pause F, et al. The CEACAM1 tumor suppressor is an ATM and p53-regulated gene required for the induction of cellular senescence by DNA damage. Oncogenesis. 2012;1:e7 pubmed 出版商
  21. Ogiwara H, Kohno T. CBP and p300 histone acetyltransferases contribute to homologous recombination by transcriptionally activating the BRCA1 and RAD51 genes. PLoS ONE. 2012;7:e52810 pubmed 出版商
  22. Conradt L, Henrich A, Wirth M, Reichert M, Lesina M, Algül H, et al. Mdm2 inhibitors synergize with topoisomerase II inhibitors to induce p53-independent pancreatic cancer cell death. Int J Cancer. 2013;132:2248-57 pubmed 出版商
  23. Anderson V, Walton M, Eve P, Boxall K, Antoni L, Caldwell J, et al. CCT241533 is a potent and selective inhibitor of CHK2 that potentiates the cytotoxicity of PARP inhibitors. Cancer Res. 2011;71:463-72 pubmed 出版商